In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

CardioNet gets $110mm with equity bridge financing

Executive Summary

CardioNet has raised $110mm through an equity bridge financing. Participants included previous backers Sanderling Ventures, Hambrecht & Quist Capital, and Foundation Medical Partners. Citigroup Global Markets and Sun Trust Robinson Humphrey served as co-placement agents. The company has developed a wireless cardiac outpatient system that provides real-time arrhythmia monitoring for ambulatory patients. It recently acquired PDSHeart, a cardiac monitoring service company.

Deal Industry
  • Medical Devices
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies